Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.
[legionellosis]
The
activity
of
solithromycin
was
evaluated
against
clinical
Legionella
pneumophila
serogroup
1
(
Lp
1
)
isolates
(
n
=
196
)
collected
in
Ontario
,
Canada
,
from
1980
to
2011
.
Its
in
vitro
activity
was
compared
to
that
of
azithromycin
(
AZM
)
using
the
broth
microdilution
method
.
Solithromycin
had
a
MIC
50
of
≤
0
.
015
μg
/
ml
and
a
MIC
90
of
0
.
031
μg
/
ml
,
making
its
activity
at
least
8
-
fold
to
32
-
fold
higher
than
that
of
AZM
(
MIC
50
and
MIC
90
,
0
.
125
μg
/
ml
and
1
μg
/
ml
,
respectively
)
.
Ninety
-
nine
percent
of
the
isolates
had
MICs
for
solithromycin
ranging
from
≤
0
.
015
μg
/
ml
to
0
.
031
μg
/
ml
,
whereas
83
.
6
%
of
the
isolates
showed
MICs
for
AZM
ranging
from
0
.
062
μg
/
ml
to
0
.
25
μg
/
ml
.
Interestingly
,
96
.
7
%
(
30
out
of
31
clinical
isolates
)
identified
with
higher
AZM
MICs
(
0
.
5
μg
/
ml
to
2
μg
/
ml
)
belonged
to
the
clinically
prevalent
sequence
type
1
.
To
investigate
the
intracellular
activity
of
solithromycin
,
in
vitro
invasion
assays
were
also
performed
against
a
subset
of
representative
Lp
1
isolates
internalized
within
human
lung
epithelial
cells
.
Solithromycin
and
AZM
both
inhibited
growth
of
all
intracellular
Lp
1
isolates
at
1
×
or
8
×
MICs
,
displaying
bacteriostatic
effects
,
as
would
be
expected
with
protein
synthesis
inhibitor
rather
than
bactericidal
activity
.
Solithromycin
demonstrated
the
highest
in
vitro
and
intracellular
potency
against
all
Lp
1
isolates
compared
to
AZM
.
Given
the
rapid
spread
of
resistance
mechanisms
among
respiratory
pathogens
and
the
reported
treatment
failures
in
legionellosis
,
the
development
of
this
new
fluoroketolide
,
already
in
phase
3
oral
clinical
studies
,
constitutes
a
promising
alternative
option
for
the
treatment
of
legionellosis
.
Diseases
Validation
Diseases presenting
"reported treatment failures in legionellosis, the development of this new fluoroketolide"
symptom
legionellosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom